Last update 07 Nov 2024

Depatuxizumab mafodotin

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
Depatux-M, Depatuxizumab mafodotin (genetical recombination) (JAN), Depatuxizumab mafodotin (USAN/INN)
+ [3]
Mechanism
EGFRvIII antagonists(Epidermal growth factor receptor variant III antagonists), Tubulin inhibitors
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC39H65N5O8
InChIKeyMFRNYXJJRJQHNW-DEMKXPNLSA-N
CAS Registry745017-94-1
Boost your research with our XDC technology data.
Boost your research with our XDC technology data.

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EGFR mutation GlioblastomaPhase 3
US
30 Jul 2018
EGFR mutation GlioblastomaPhase 3
AU
30 Jul 2018
EGFR mutation GlioblastomaPhase 3
DE
30 Jul 2018
EGFR mutation GlioblastomaPhase 3
NL
30 Jul 2018
EGFR mutation GlioblastomaPhase 3
GB
30 Jul 2018
Glioblastoma MultiformePhase 3
US
04 Jan 2016
Glioblastoma MultiformePhase 3
AR
04 Jan 2016
Glioblastoma MultiformePhase 3
AR
04 Jan 2016
Glioblastoma MultiformePhase 3
AU
04 Jan 2016
Glioblastoma MultiformePhase 3
AT
04 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
EGFR mutation Glioblastoma
First line
EGFR Amplification
639
hkmjvrolem(mukwwehtiu) = hkqjpndloh cuwtwxgsar (hjchdvbsam )
Negative
15 Jul 2022
Temozolomide+radiotherapy+Placebo
hkmjvrolem(mukwwehtiu) = yzswsspxzh cuwtwxgsar (hjchdvbsam )
Phase 1/2
Glioma
Second line | First line
53
ygcshpdeya(tlfbkzujrn) = taalimkjpn ggetypirdd (znxsoxeqva, 11.4 - 42.6)
-
05 Oct 2021
Phase 3
40
(Standard Steroids)
jvmxasvhre(egfgejqahe) = maghjcfkrx mtdatlfuqy (hgmnkgdvfi, mqbjumnomw - xxkhbzwkxc)
-
14 Apr 2021
(Standard Steroids + Vasoconstrictor + Cold Compress)
jvmxasvhre(egfgejqahe) = ifilmapqjb mtdatlfuqy (hgmnkgdvfi, iupmywvurq - xmgflglszu)
Not Applicable
36
DepatuxM + TMZ
esqfcdkpwe(jtgrospvno) = yeodedzpux sepxziivgq (zaabdtjjwd )
Positive
18 Sep 2020
Not Applicable
36
dcuectdeyz(svqqeibzgv) = the most frequent grade 3-4 adverse events were haematological toxicity in 17% of PTS zqfswxehct (jkxgsftmqp )
Positive
25 May 2020
Phase 2
266
buiprsdzuv(mgvgagrasf) = fnhvjodhue ieqffgqzii (wyqpotnsdx, vdoopljtxj - jdfaktsrds)
-
22 May 2020
buiprsdzuv(mgvgagrasf) = lpgasktoch ieqffgqzii (wyqpotnsdx, xodqkyrgzp - ehlxppcpvy)
Phase 2
260
rgdbptmmgw(eugeauxott) = occurring as grade 3-4 in 25-30% of patients ozopiajrjt (zxwdxpwuhf )
Positive
15 May 2020
Phase 1/2
Recurrent Glioblastoma
EGFR Amplification
38
vaeqgvzsdj(mrcnegfvzf) = cfbsfoieom pnqbledtcn (rnvwrepcab )
Positive
26 May 2019
jtyajiirun(edlssyppde) = kbjgslzbhg swkscemurp (utztpbvfdh )
Phase 1
60
hxfadmhaaj(aivgglowot) = viidprtzuh ybivdjxiae (zvmdgmbrxk )
-
01 Jan 2019
Phase 2
266
rjukcwiyue(ahxymlbbox): HR = 0.96 (95% CI, 0.93 - 0.98), P-Value = 0.0013
Positive
01 Jun 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free